{"pmid":32489031,"title":"[Thoughts and suggestions on analysis of death cases report during COVID-19 epidemic].","text":["[Thoughts and suggestions on analysis of death cases report during COVID-19 epidemic].","It is an essential task to discuss the death cases for clinicians. During the emergent public events, the report and analysis of death cases is of far-reaching significance. The epidemic of coronavirus disease 2019(COVID-19) has brought huge losses to China, and the medical system has been sustaining tremendous pressure. The best weapon to defeat the epidemic is medical data and related scientific research, of which the systematic analysis and efficient use of death cases is a key step. Based on the incomplete record of death case report, the lack of humanistic perspective and patient report, every department and institution is facing great challenge in terms of data management. Given that the relevant systems need to be improved, and that the integration of standardized reports and clinical research is not mature,as well as other problems, we put forward several methodological suggestions: 1 in circle Establish national medical and health data center and improve relevant laws and regulations. 2 in circle Increase investment in medical data management and start data collection and analysis as early as possible during the epidemic. 3 in circle Refine the content of death case report and promote the standardization of report. 4 in circle Pay close attention to the report of death cases, review, summary and analysis. More importantly, we should continue to build and improve platforms and programs related to disease control, carry out epidemic-associated scientific research, enhance the managing efficiency of public health data, elevate the anti-risk capability of our medical system, and promote the steady progress of the health China strategy.","Zhongguo Zhong Yao Za Zhi","Li, Bo","Yan, Yu-Meng","Li, Ze-Yu","Chen, Teng-Fei","Guo, Yu-Hong","Hu, Jing","Feng, Shuo","Su, Xiang-Fei","Wang, Tian-Yuan","Li, Ping","Wang, Qiang","Liu, Qing-Quan","32489031"],"abstract":["It is an essential task to discuss the death cases for clinicians. During the emergent public events, the report and analysis of death cases is of far-reaching significance. The epidemic of coronavirus disease 2019(COVID-19) has brought huge losses to China, and the medical system has been sustaining tremendous pressure. The best weapon to defeat the epidemic is medical data and related scientific research, of which the systematic analysis and efficient use of death cases is a key step. Based on the incomplete record of death case report, the lack of humanistic perspective and patient report, every department and institution is facing great challenge in terms of data management. Given that the relevant systems need to be improved, and that the integration of standardized reports and clinical research is not mature,as well as other problems, we put forward several methodological suggestions: 1 in circle Establish national medical and health data center and improve relevant laws and regulations. 2 in circle Increase investment in medical data management and start data collection and analysis as early as possible during the epidemic. 3 in circle Refine the content of death case report and promote the standardization of report. 4 in circle Pay close attention to the report of death cases, review, summary and analysis. More importantly, we should continue to build and improve platforms and programs related to disease control, carry out epidemic-associated scientific research, enhance the managing efficiency of public health data, elevate the anti-risk capability of our medical system, and promote the steady progress of the health China strategy."],"journal":"Zhongguo Zhong Yao Za Zhi","authors":["Li, Bo","Yan, Yu-Meng","Li, Ze-Yu","Chen, Teng-Fei","Guo, Yu-Hong","Hu, Jing","Feng, Shuo","Su, Xiang-Fei","Wang, Tian-Yuan","Li, Ping","Wang, Qiang","Liu, Qing-Quan"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32489031","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.19540/j.cnki.cjcmm.20200306.501","keywords":["2019-ncov","covid-19","data","death case report","epidemic situation","standardization"],"locations":["China","Establish","China"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1668623433656696832,"score":9.490897,"similar":[{"pmid":32489030,"title":"[Thoughts and suggestions on arrangement, analysis and summary of medical data during COVID-19 epidemic].","text":["[Thoughts and suggestions on arrangement, analysis and summary of medical data during COVID-19 epidemic].","The analysis and utilization of clinical scientific research data is an effective means to promote the progress of diagnosis and treatment, and a key step in the development of medical sciences. During the epidemic of coronavirus disease 2019(COVID-19), how to transform the limited diagnostic data into clinical research resources has attracted much attention. Based on the low efficiency of data collection and extraction, the inconsistency of data analysis, the irregularity of data report and the high timeliness of data update during the epidemic, this paper briefly analyzed the background and reasons of data application under the current situation, and then discusses the problems and feasible solutions of clinical data applications under the epidemic situation and, more importantly, for future medical clinical research methods. We put forward several methodological suggestions: 1 in circle gradually improve the medical big data model and establish the national medical health data center; 2 in circle improve the scientific research literacy of medical staff and popularize the basic skills and knowledge of GCP; 3 in circle promote a scientific, networked and shared data collection and management mode; 4 in circle use the mixed research method and collective analysis to improve the efficiency of clinical data analysis; pay attention to narration of the medical feelings and emphasize the humanistic data of clinical medicine. It is expected to promote the standardized and reasonable use of clinical scientific research data, the rigorous integration of expert opinions, and ultimately the development of big data for national health care.","Zhongguo Zhong Yao Za Zhi","Yan, Yu-Meng","Li, Bo","Li, Ze-Yu","Lian, Bo","Su, Xiang-Fei","Wang, Tian-Yuan","Li, Ping","Wang, Qiang","Cheng, Jin-Lian","Yang, Zhong-Qi","32489030"],"abstract":["The analysis and utilization of clinical scientific research data is an effective means to promote the progress of diagnosis and treatment, and a key step in the development of medical sciences. During the epidemic of coronavirus disease 2019(COVID-19), how to transform the limited diagnostic data into clinical research resources has attracted much attention. Based on the low efficiency of data collection and extraction, the inconsistency of data analysis, the irregularity of data report and the high timeliness of data update during the epidemic, this paper briefly analyzed the background and reasons of data application under the current situation, and then discusses the problems and feasible solutions of clinical data applications under the epidemic situation and, more importantly, for future medical clinical research methods. We put forward several methodological suggestions: 1 in circle gradually improve the medical big data model and establish the national medical health data center; 2 in circle improve the scientific research literacy of medical staff and popularize the basic skills and knowledge of GCP; 3 in circle promote a scientific, networked and shared data collection and management mode; 4 in circle use the mixed research method and collective analysis to improve the efficiency of clinical data analysis; pay attention to narration of the medical feelings and emphasize the humanistic data of clinical medicine. It is expected to promote the standardized and reasonable use of clinical scientific research data, the rigorous integration of expert opinions, and ultimately the development of big data for national health care."],"journal":"Zhongguo Zhong Yao Za Zhi","authors":["Yan, Yu-Meng","Li, Bo","Li, Ze-Yu","Lian, Bo","Su, Xiang-Fei","Wang, Tian-Yuan","Li, Ping","Wang, Qiang","Cheng, Jin-Lian","Yang, Zhong-Qi"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32489030","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.19540/j.cnki.cjcmm.20200302.504","keywords":["2019-ncov","covid-19","clinical research","data application","epidemic situation","mixed research"],"weight":0,"_version_":1668623433678716928,"score":523.5914},{"pmid":32340092,"title":"[Suggestions on reforming and improving the prevention and treatment system for major epidemic diseases in China].","text":["[Suggestions on reforming and improving the prevention and treatment system for major epidemic diseases in China].","Based on systematic review of the role of clinical treatment, disease control and scientific research, and combining with the problems exposed by the COVID-19 epidemic, suggestions were proposed to reform and improve the prevention and treatment system for major epidemics diseases in China. In clinical treatment, it is necessary to enhance clinical staff's awareness of law-based reporting, capabilities of syndromic surveillance, the use of infectious diseases reporting systems, and to improve national or local monitoring platforms for emerging infectious diseases detection. In terms of disease control, it is important to provide authorities to disease control departments through laws and regulations, improve the quantity and quality of related human resources, and strengthen the applied research and technical readiness targeted infections disease prevention, control and emergency preparedness. As for scientific research in major epidemic response, it is essential to strengthen research projects guided by national requests, build research institutions that can \"make a final decision\", establish national and regional key laboratories, and strengthen strategic technical reserve for emergency disease control and treatment.","Zhonghua Liu Xing Bing Xue Za Zhi","Li, L M","Zhan, S Y","Chi, H","Deng, Y","Wang, L","Wang, B","32340092"],"abstract":["Based on systematic review of the role of clinical treatment, disease control and scientific research, and combining with the problems exposed by the COVID-19 epidemic, suggestions were proposed to reform and improve the prevention and treatment system for major epidemics diseases in China. In clinical treatment, it is necessary to enhance clinical staff's awareness of law-based reporting, capabilities of syndromic surveillance, the use of infectious diseases reporting systems, and to improve national or local monitoring platforms for emerging infectious diseases detection. In terms of disease control, it is important to provide authorities to disease control departments through laws and regulations, improve the quantity and quality of related human resources, and strengthen the applied research and technical readiness targeted infections disease prevention, control and emergency preparedness. As for scientific research in major epidemic response, it is essential to strengthen research projects guided by national requests, build research institutions that can \"make a final decision\", establish national and regional key laboratories, and strengthen strategic technical reserve for emergency disease control and treatment."],"journal":"Zhonghua Liu Xing Bing Xue Za Zhi","authors":["Li, L M","Zhan, S Y","Chi, H","Deng, Y","Wang, L","Wang, B"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32340092","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3760/cma.j.cn112338-20200407-00521","keywords":["covid-19","control and treatment of major epidemic diseases","suggestions"],"locations":["China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1666138495066832896,"score":234.8469},{"pmid":32498493,"title":"[Consideration on improving public health emergency management ability of current medical health system].","text":["[Consideration on improving public health emergency management ability of current medical health system].","COVID-19 is a Public Health Emergency of International Concern (PHEIC). Direct economic loss is expected to be much more than that of SARS outbreak in 2003. The risk factors of COVID-19 epidemic at the early stage incluede the misjudgment of the epidemic, delay in reporting this emerging infectious disease, nosocomial infection-caused transmission of the virus into local communities, and weak public health interventions. The infection rate (or the incidence) reflects the prophylactic effect in population. Case fatality reflects the therapeutic effect of clinical intervention. There were sufficient medical resources at the national top levels accumulated in Wuhan. Furthermore, medical professionals and sufficient medical supplies from other provinces have been assigned to join in the fighting against the epidemic in Wuhan. However, the case fatality in Wuhan has being kept the highest in China, indicating that clinical treatment for this virus-caused emerging infectious disease, whose pathogenesis remains to be elucidated, had a limited effect in controlling this epidemic. The unusual, extremely costly public health interventions including the temporarily city quarantine and transportation ban issued by the central government are crucial in controlling this epidemic. The control of epidemic indicates the importance of public health measures but also reflected its insufficient capacity in China. Recently, profit-seeking mechanism run in Chinese health service system disorganized the balance of clinical service and public health service patterns in China, promoting the vicious circle of \"attaching importance to clinical treatment and despising disease prophylaxis\" , damaging the infrastructure of public health capacity, thus contributing to the formation of the inevitability in various fortuities of public health emergency. To strength the capacity of our medical service system to respond to public health emergency efficiently, two key issues should be considered. First, public health service, which should be fixed as the health section of the governments' public services by the law, must be greatly improved to meet the increasing health needs of the publics. Second, the vicious circle of profit-seeking-caused \"attaching importance to clinical treatment and despising disease prophylaxis\" should be immediately broken to optimize the national health service system in China by increasing the investment in public health service.","Zhonghua Liu Xing Bing Xue Za Zhi","Cao, G W","Zhang, B X","Chen, X P","32498493"],"abstract":["COVID-19 is a Public Health Emergency of International Concern (PHEIC). Direct economic loss is expected to be much more than that of SARS outbreak in 2003. The risk factors of COVID-19 epidemic at the early stage incluede the misjudgment of the epidemic, delay in reporting this emerging infectious disease, nosocomial infection-caused transmission of the virus into local communities, and weak public health interventions. The infection rate (or the incidence) reflects the prophylactic effect in population. Case fatality reflects the therapeutic effect of clinical intervention. There were sufficient medical resources at the national top levels accumulated in Wuhan. Furthermore, medical professionals and sufficient medical supplies from other provinces have been assigned to join in the fighting against the epidemic in Wuhan. However, the case fatality in Wuhan has being kept the highest in China, indicating that clinical treatment for this virus-caused emerging infectious disease, whose pathogenesis remains to be elucidated, had a limited effect in controlling this epidemic. The unusual, extremely costly public health interventions including the temporarily city quarantine and transportation ban issued by the central government are crucial in controlling this epidemic. The control of epidemic indicates the importance of public health measures but also reflected its insufficient capacity in China. Recently, profit-seeking mechanism run in Chinese health service system disorganized the balance of clinical service and public health service patterns in China, promoting the vicious circle of \"attaching importance to clinical treatment and despising disease prophylaxis\" , damaging the infrastructure of public health capacity, thus contributing to the formation of the inevitability in various fortuities of public health emergency. To strength the capacity of our medical service system to respond to public health emergency efficiently, two key issues should be considered. First, public health service, which should be fixed as the health section of the governments' public services by the law, must be greatly improved to meet the increasing health needs of the publics. Second, the vicious circle of profit-seeking-caused \"attaching importance to clinical treatment and despising disease prophylaxis\" should be immediately broken to optimize the national health service system in China by increasing the investment in public health service."],"journal":"Zhonghua Liu Xing Bing Xue Za Zhi","authors":["Cao, G W","Zhang, B X","Chen, X P"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32498493","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.3760/cma.j.cn112338-20200304-00247","keywords":["covid-19","health service system","profit-seeking","public health","rebuild"],"locations":["Wuhan","Wuhan","Wuhan","China","China","Chinese","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1668804508835119105,"score":214.41368},{"pmid":32288414,"pmcid":"PMC7137855","title":"Demand Analysis and Management Suggestion: Sharing Epidemiological Data Among Medical Institutions in Megacities for Epidemic Prevention and Control.","text":["Demand Analysis and Management Suggestion: Sharing Epidemiological Data Among Medical Institutions in Megacities for Epidemic Prevention and Control.","During the prevention of coronavirus disease 2019 (COVID-19), epidemiological data is essential for controlling the source of infection, cutting off the route of transmission, and protecting vulnerable populations. Following Law of the People's Republic of China on Prevention and Treatment of Infectious Diseases and other related regulations, medical institutions have been authorized to collect the detailed information of patients, while it is still a formidable task in megacities because of the significant patient mobility and the existing information sharing barrier. As a smart city which strengthens precise epidemic prevention and control, Shanghai has established a multi-department platform named \"one-net management\" on dynamic information monitoring. By sharing epidemiological data with medical institutions under a safe environment, we believe that the ability to prevent and control epidemics among medical institutions will be effectively and comprehensively improved.","J Shanghai Jiaotong Univ Sci","Cai, Qinyi","Mi, Yiqun","Chu, Zhaowu","Zheng, Yuanyi","Chen, Fang","Liu, Yicheng","32288414"],"abstract":["During the prevention of coronavirus disease 2019 (COVID-19), epidemiological data is essential for controlling the source of infection, cutting off the route of transmission, and protecting vulnerable populations. Following Law of the People's Republic of China on Prevention and Treatment of Infectious Diseases and other related regulations, medical institutions have been authorized to collect the detailed information of patients, while it is still a formidable task in megacities because of the significant patient mobility and the existing information sharing barrier. As a smart city which strengthens precise epidemic prevention and control, Shanghai has established a multi-department platform named \"one-net management\" on dynamic information monitoring. By sharing epidemiological data with medical institutions under a safe environment, we believe that the ability to prevent and control epidemics among medical institutions will be effectively and comprehensively improved."],"journal":"J Shanghai Jiaotong Univ Sci","authors":["Cai, Qinyi","Mi, Yiqun","Chu, Zhaowu","Zheng, Yuanyi","Chen, Fang","Liu, Yicheng"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32288414","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s12204-020-2166-3","keywords":["big data sharing","epidemic prevention and control","medical institutions","megacities"],"locations":["Shanghai"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138491370602499,"score":199.80307},{"pmid":32376587,"pmcid":"PMC7167318","title":"[Conducting clinical studies during the epidemics of communicable diseases: perspectives of methodology and health economics].","text":["[Conducting clinical studies during the epidemics of communicable diseases: perspectives of methodology and health economics].","In the setting of epidemics of communicable diseases, early initiation of epidemiological and clinical data collection and analysis and conducting relevant researches are essential to the success of epidemic containment. The coronavirus disease 2019 (COVID-19), starting initially as an epidemic in China in late 2019 and now becoming a pandemic globally, poses grave challenges to the global health care systems while also provides an opportunity for studying infectious diseases in the perspective of methodology. The authors propose the evaluation methods for case reports, randomized controlled trials (RCTs), real-world evidence studies and health economics researches during an epidemic. Case reports, which are of important value for health care workers during outbreaks of infectious diseases, should be written in standard format and style and published following a strict peer review process. RCTs provides the gold standard for evaluating the effectiveness of a given treatment for the patients from the outbreaks. We review the potential challenges faced in conducting RCTs during the outbreaks. The real-world data collected from the cases in designated hospitals allow the verification of the safety and effectiveness of the intervention measures. The data from health economics research also provide important support for optimizing communicable disease prevention and control strategies. Herein we summarize the health economics research methods, study design, and technical points during the outbreaks. We recommend that clinical research and health economics research be incorporated into the prevention and control plan and measures be taken to ensure both the standards and feasibility of these studies to improve the response capacity against outbreaks of communicable diseases.","Nan Fang Yi Ke Da Xue Xue Bao","Gong, Mengchun","Liu, Li","Wu, Chen","Yang, Yue","Shen, Yang","Li, Jie","Lin, Kaicheng","Guo, Yi","Wei, Hongyun","Xu, Zeyu","Zhu, Hong","32376587"],"abstract":["In the setting of epidemics of communicable diseases, early initiation of epidemiological and clinical data collection and analysis and conducting relevant researches are essential to the success of epidemic containment. The coronavirus disease 2019 (COVID-19), starting initially as an epidemic in China in late 2019 and now becoming a pandemic globally, poses grave challenges to the global health care systems while also provides an opportunity for studying infectious diseases in the perspective of methodology. The authors propose the evaluation methods for case reports, randomized controlled trials (RCTs), real-world evidence studies and health economics researches during an epidemic. Case reports, which are of important value for health care workers during outbreaks of infectious diseases, should be written in standard format and style and published following a strict peer review process. RCTs provides the gold standard for evaluating the effectiveness of a given treatment for the patients from the outbreaks. We review the potential challenges faced in conducting RCTs during the outbreaks. The real-world data collected from the cases in designated hospitals allow the verification of the safety and effectiveness of the intervention measures. The data from health economics research also provide important support for optimizing communicable disease prevention and control strategies. Herein we summarize the health economics research methods, study design, and technical points during the outbreaks. We recommend that clinical research and health economics research be incorporated into the prevention and control plan and measures be taken to ensure both the standards and feasibility of these studies to improve the response capacity against outbreaks of communicable diseases."],"journal":"Nan Fang Yi Ke Da Xue Xue Bao","authors":["Gong, Mengchun","Liu, Li","Wu, Chen","Yang, Yue","Shen, Yang","Li, Jie","Lin, Kaicheng","Guo, Yi","Wei, Hongyun","Xu, Zeyu","Zhu, Hong"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376587","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.12122/j.issn.1673-4254.2020.03.11","keywords":["covid-19","epidemics","health economics and outcome research","randomized controlled trials","real-world evidence studies"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666262687598772224,"score":185.6655}]}